Exozymes Inc. financial data

Symbol
EXOZ on Nasdaq
Location
750 Royal Oaks Dr, Monrovia, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 638 %
Debt-to-equity 31.5 %
Return On Equity -105 % -138%
Return On Assets -79.5 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.39M shares +34.1%
Common Stock, Shares, Outstanding 8.39M shares +34.1%
Common Stock, Value, Issued 8 USD +33.3%
Weighted Average Number of Shares Outstanding, Basic 8.39M shares +34.1%
Weighted Average Number of Shares Outstanding, Diluted 8.39M shares +34.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3.23M USD +68.2%
General and Administrative Expense 5.78M USD +47%
Operating Income (Loss) -9M USD -56.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.34M USD -38.1%
Net Income (Loss) Attributable to Parent -8.34M USD -62.8%
Earnings Per Share, Basic -1 USD/shares 0%
Earnings Per Share, Diluted -1 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.1M USD +2080%
Assets, Current 5.61M USD +294%
Property, Plant and Equipment, Net 763K USD +3.17%
Operating Lease, Right-of-Use Asset 1.12M USD -19.5%
Assets 7.72M USD +117%
Accounts Payable, Current 904K USD -0.47%
Liabilities, Current 1.24M USD -78.7%
Operating Lease, Liability, Noncurrent 927K USD -24.2%
Liabilities 2.34M USD -67.3%
Retained Earnings (Accumulated Deficit) -18.4M USD -82.5%
Stockholders' Equity Attributable to Parent 5.37M USD
Liabilities and Equity 7.72M USD +117%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.13M USD -503%
Net Cash Provided by (Used in) Financing Activities -43.3K USD +52.7%
Net Cash Provided by (Used in) Investing Activities -31K USD +78.2%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 8.39M shares +34.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.21M USD -2656%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.1M USD +2080%
Deferred Tax Assets, Valuation Allowance 3.07M USD +59.2%
Operating Lease, Liability 1.2M USD -17%
Depreciation 70.5K USD +12.3%
Payments to Acquire Property, Plant, and Equipment 31K USD -79.1%
Lessee, Operating Lease, Liability, to be Paid 1.39M USD -20%
Property, Plant and Equipment, Gross 1.71M USD +21.8%
Operating Lease, Liability, Current 274K USD +22.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 368K USD +2.74%
Lessee, Operating Lease, Liability, to be Paid, Year One 358K USD +2.74%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 186K USD -35.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 379K USD +2.8%
Deferred Tax Assets, Operating Loss Carryforwards 1.31M USD +157%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 379K USD
Operating Lease, Payments 86.3K USD
Additional Paid in Capital 23.8M USD +266%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 482K USD -10.6%
Interest Expense 44.6K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%